NanoViricides, Inc. (NASDAQ:NNVC)

BRIEF

published on 11/15/2024 at 12:35, 1 month 6 days ago

NanoViricides fait passer le NV-387 aux essais de phase II pour le traitement de multiples infections virales

NanoViricides NV-387 Rapport Financier Essais Cliniques Médicament Antiviral
BRIEF

published on 11/15/2024 at 12:35, 1 month 6 days ago

NanoViricides Advances NV-387 to Phase II Trials for Multiple Viral Infections

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Drug
PRESS RELEASE

published on 11/15/2024 at 12:30, 1 month 6 days ago

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID
NanoViricides, Inc. files Quarterly Report on Form 10-Q with the SEC, highlights financial results and progress on NV-387 antiviral drug for various infections including MPox and RSV

NanoViricides NV-387 Quarterly Report SEC Filing Antiviral Drug
BRIEF

published on 11/04/2024 at 06:05, 1 month 17 days ago

NanoViricides présente sa nouvelle technologie à la conférence Spartan Capital Investors 2024

NanoViricides NV-387 Nanomédicaments Antiviraux Conférence Sur La Capitale Spartiate Dr Anil R. Diwan
BRIEF

published on 11/04/2024 at 06:05, 1 month 17 days ago

NanoViricides Presents at Spartan Capital Investors Conference 2024

NanoViricides NV-387 Antiviral Nanomedicines Spartan Capital Conference Dr. Anil R. Diwan
PRESS RELEASE

published on 11/04/2024 at 06:00, 1 month 17 days ago

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am
NanoViricides, Inc. to present corporate update at Spartan Capital Investors Conference on NV-387 antiviral drug development with strong market potential

NV-387 NanoViricides Inc. Market Potential Antiviral Drug Spartan Capital Investors Conference
BRIEF

published on 10/22/2024 at 12:35, 1 month 30 days ago

NanoViricides President to Present at PODD Conference

NanoViricides NV-387 Drug Delivery PODD Conference Antiviral Treatments
BRIEF

published on 10/22/2024 at 12:35, 1 month 30 days ago

Le président de NanoViricides fera une présentation à la conférence PODD

NanoViricides NV-387 Administration De Médicaments Conférence PODD Traitements Antiviraux
PRESS RELEASE

published on 10/22/2024 at 12:30, 1 month 30 days ago

NanoViricides President Dr. Diwan to Present at the PODD Conference
NanoViricides announces President Dr. Anil R. Diwan to speak at PODD Conference about revolutionary antiviral nanomedicines. Conference focuses on drug delivery partnerships and trends

NanoViricides Drug Delivery Antiviral Nanomedicines PODD Conference Anil R. Diwan
BRIEF

published on 10/15/2024 at 12:35, 2 months 6 days ago

Innovative Antiviral Technology Discussed in Recent NanoViricides Podcast

NanoViricides NV-387 Antiviral Treatment Phase II Trials Nanomedicine Technology

Published on 12/21/2024 at 01:30, 14 hours 16 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 16 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 41 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 46 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 16 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 54 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 15 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 49 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 45 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 28 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 28 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 46 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 46 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 51 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News